02994nam 22007694a 450 991081089750332120200520144314.00-19-770665-71-280-84585-697866108458590-19-974824-11-4294-5923-910.1093/oso/9780195187762.001.0001(CKB)1000000000471467(EBL)2012824(OCoLC)923712716(SSID)ssj0000153184(PQKBManifestationID)11147421(PQKBTitleCode)TC0000153184(PQKBWorkID)10391781(PQKB)11249681(Au-PeEL)EBL2012824(CaPaEBR)ebr10375120(CaONFJC)MIL84585(MiAaPQ)EBC2012824(OCoLC)1406787374(StDuBDS)9780197706657(EXLCZ)99100000000047146720051228d2007 uy 0engurcn|||||||||txtccrFalse hope bone marrow transplantation for breast cancer /Richard A. Rettig ... [et al.]1st ed.Oxford ;New York Oxford University Press20071 online resource (368 p.)Oxford scholarship onlineFormerly CIP.UkPreviously issued in print: 2007.0-19-518776-8 Includes bibliographical references (p. 315-341) and index.Breast cancer patients and the emergence of a treatment -- Jumping the gun -- Court trials -- Litigation strategies -- Entrepreneurial oncology -- Government mandates -- Technology assessments -- Clinical trials -- Denouement -- Values in conflict.In the late 1990s, a promising new treatment for breast cancer emerged: high-dose chemotherapy with autologous bone marrow transplantation or HDC/ABMT. This text tells of the rise and demise of HDC/ABMT for metastatic and early stage breast cancer.Oxford scholarship online.BreastCancerChemotherapyUnited StatesHistoryBone marrowTransplantationUnited StatesHistoryAutotransplantationUnited StatesHistoryBreastCancerChemotherapyComplicationsBone marrowTransplantationComplicationsAutotransplantationComplicationsBreastCancerChemotherapyHistory.Bone marrowTransplantationHistory.AutotransplantationHistory.BreastCancerChemotherapyComplications.Bone marrowTransplantationComplications.AutotransplantationComplications.616.99/449061Rettig Richard A1616181MiAaPQMiAaPQMiAaPQBOOK9910810897503321False hope4075218UNINA